Related Experiment Video
Updated: Sep 9, 2025

15:00
Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies
Published on: February 3, 2023
2.6K
Validating the current duration approach for measuring infertility prevalence using novel app data from the USA.
Suzanne O Bell1, Sungsik Hwang2, Shannon Malloy3
1Department of Population Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Human Reproduction (Oxford, England)
|September 2, 2025
Summary
The current duration (CD) approach for estimating infertility shows comparable results to the prospective cohort method when its assumptions are addressed. This validates CD for studying infertility patterns in diverse populations using app data.
Area of Science:
- Reproductive Health
- Epidemiology
- Biostatistics
Background:
- The current duration (CD) approach offers a feasible, cost-effective method for assessing population infertility compared to traditional prospective cohort studies.
- However, rigorous testing of CD approach assumptions using population-based samples is lacking, limiting its widespread adoption.
Purpose of the Study:
- To evaluate whether the assumptions of the current duration (CD) approach for estimating population infertility are met.
- To compare infertility estimates derived from the CD approach with those from the gold-standard incident prospective cohort approach using fertility app data.
Main Methods:
- Utilized prospective cohort data from 167,451 users of a fertility smartphone application (2015-2022).
- Generated six CD samples (17,196-26,259 participants) from the same data source for comparison.
- Tested CD approach assumptions and estimated 12-month infertility prevalence using both prospective and CD methods, stratified by age, education, parity, and poverty.
Main Results:
- Demonstrated clear violation of one CD assumption and suggestive evidence of another.
- The prospective cohort method yielded a 12-month infertility prevalence of 36.1%, while the adjusted CD estimate was 37.0%.
- Infertility patterns by user characteristics were similar across both methods, with higher prevalence in older, nulliparous, less educated, and poorer individuals.
Conclusions:
- Despite assumption violations, the CD approach, once adjusted, provides comparable infertility prevalence estimates and patterns to the prospective cohort design within the same sample.
- The CD approach can facilitate infertility research in populations lacking existing estimates, provided assumption violations are statistically addressed.
- App-based estimates may not represent US population-level infertility due to potential underreporting and sample characteristics.
More Related Videos
Related Concept Videos
Infertility in Males
331
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
331
Infertility in Females
401
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
401
Kaplan-Meier Approach
258
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
258

